Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-08 04:45 | 2024-05-29 | GNLX | GENELUX Corp | Smither John W | Director | Pharmaceutical Preparations | BUY | $0.00 | 6,250 | $0 | 13,170 | +90.3% |
| 2023-09-15 03:18 | 2023-09-13 | GNLX | GENELUX Corp | Smither John W | Director | Pharmaceutical Preparations | SALE | $20.78 | 900 | $18,702 | 6,920 | -11.5% |
| 2021-03-11 23:59 | 2021-03-10 | ARQT | Arcutis Biotherapeutics Inc. | Smither John W | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $32.90 | 1,750 | $57,575 | 86,715 | -2.0% |
| 2021-03-04 00:48 | 2021-03-01 | ARQT | Arcutis Biotherapeutics Inc. | Smither John W | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $34.20 | 773 | $26,440 | 24,425 | -3.1% |
| 2021-02-13 01:32 | 2021-02-10 | ARQT | Arcutis Biotherapeutics Inc. | Smither John W | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $35.64 | 2,750 | $98,010 | 87,965 | -3.0% |
| 2021-02-03 19:23 | 2021-02-01 | ARQT | Arcutis Biotherapeutics Inc. | Smither John W | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $35.00 | 5,000 | $175,000 | 89,965 | -5.3% |
| 2021-01-22 00:41 | 2021-01-19 | ARQT | Arcutis Biotherapeutics Inc. | Smither John W | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $30.00 | 1,750 | $52,500 | 93,715 | -1.8% |
| 2020-12-16 23:14 | 2020-12-14 | ARQT | Arcutis Biotherapeutics Inc. | Smither John W | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $30.00 | 5,250 | $157,500 | 94,965 | -5.2% |
| 2020-10-02 04:00 | 2020-09-29 | ARQT | Arcutis Biotherapeutics Inc. | Smither John W | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $30.00 | 1,750 | $52,500 | 98,715 | -1.7% |
| 2015-09-25 04:38 | 2015-09-23 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $74.90 | 53,835 | $4,032,242 | 3,368 | -94.1% |
| 2015-09-23 13:00 | 2015-09-18 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $74.91 | 6,645 | $497,763 | 3,368 | -66.4% |
| 2015-09-23 13:00 | 2015-04-30 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | SALE | $45.49 | 2,041 | $92,845 | 3,368 | -37.7% |
| 2015-07-01 02:34 | 2015-06-25 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | SALE | $75.50 | 4,600 | $347,300 | 7,616 | -37.7% |
| 2015-06-26 01:33 | 2015-06-25 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | SALE | $75.50 | 4,600 | $347,300 | 10,984 | -29.5% |
| 2015-05-01 04:27 | 2015-04-30 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | SALE | $45.49 | 2,041 | $92,845 | 15,584 | -11.6% |
| 2015-03-06 02:19 | 2015-03-05 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | SALE | $48.09 | 4,200 | $201,980 | 12,216 | -25.6% |
| 2015-02-20 02:43 | 2015-02-17 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | SALE | $41.00 | 2,000 | $82,000 | 16,416 | -10.9% |
| 2015-02-03 00:26 | 2015-01-29 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | SALE | $38.00 | 1,000 | $38,000 | 18,416 | -5.2% |
| 2015-01-28 01:54 | 2015-01-23 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | SALE | $35.65 | 3,000 | $106,940 | 19,416 | -13.4% |
| 2014-12-23 02:43 | 2014-12-22 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $35.49 | 375 | $13,309 | 16,200 | -2.3% |
| 2014-11-21 00:54 | 2014-11-20 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $34.83 | 375 | $13,061 | 16,200 | -2.3% |
| 2014-10-20 21:44 | 2014-10-20 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $32.53 | 375 | $12,199 | 16,200 | -2.3% |
| 2014-09-23 00:04 | 2014-09-22 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $35.61 | 375 | $13,354 | 16,200 | -2.3% |
| 2014-08-21 03:13 | 2014-08-20 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $35.04 | 375 | $13,140 | 16,200 | -2.3% |
| 2014-07-22 00:15 | 2014-07-21 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $33.40 | 375 | $12,525 | 16,200 | -2.3% |
| 2014-07-03 20:31 | 2014-07-02 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $40.00 | 2,250 | $90,000 | 16,200 | -12.2% |
| 2014-03-21 02:16 | 2014-03-20 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $43.78 | 1,125 | $49,253 | 10,200 | -9.9% |
| 2014-02-22 00:31 | 2014-02-20 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $49.75 | 2,250 | $111,926 | 10,200 | -18.1% |
| 2014-02-18 22:04 | 2014-02-14 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $50.00 | 1,125 | $56,250 | 10,200 | -9.9% |
| 2014-01-22 03:36 | 2014-01-21 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $42.54 | 1,125 | $47,856 | 10,200 | -9.9% |
| 2013-09-11 02:51 | 2013-09-09 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $30.02 | 40,000 | $1,200,996 | 0 | -100.0% |
| 2013-08-03 00:46 | 2013-08-01 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $26.80 | 10,000 | $268,005 | 0 | -100.0% |
| 2013-06-19 00:37 | 2013-06-17 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $26.00 | 6,000 | $156,000 | 0 | -100.0% |
| 2013-05-04 00:34 | 2013-05-01 | KYTH | N/A | Smither John W | Officer; Chief Financial Officer | Other | OPT+S | $24.11 | 4,000 | $96,429 | 0 | -100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.